Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intellipharmaceutics International Inc (NASDAQ:IPCI)

1.55
Delayed Data
As of Jun 30
 -0.03 / -1.90%
Today’s Change
1.41
Today|||52-Week Range
3.87
-23.27%
Year-to-Date
No recent news for Intellipharmaceutics International Inc.

Today’s Trading

Previous close1.58
Today’s open1.57
Day’s range1.53 - 1.60
Volume67,479
Average volume (3 months)116,197
Market cap$37.5M
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)+48.92%
Earnings growth (this year)+51.49%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RPRXRepros Therapeutics ...0.000.00%
CTRVContraVir Pharmaceut...-0.01-0.95%
EBIOEleven Biotherapeuti...-0.20-10.70%
SNTASynta Pharmaceutical...-0.01-2.98%
Data as of 06/30/2016

Financials

Last reporting dateJuly 1, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$15.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO &
Co-Chief Scientific Officer
Isa Odidi
President, Chief Operating Officer &
Director
Amina Odidi
Corporate headquarters
Toronto, Ontario

Forecasts

Partner Offers

Search for Jobs